Article Details

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Consensus Rating of "Hold" from Analysts

Retrieved on: 2020-12-18 06:22:30

Tags for this article:

Click the tags to see associated articles and topics

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Consensus Rating of "Hold" from Analysts. View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-lxrx-consensus-analyst-rating-2020-12/

Excerpt

<b>WINTON GROUP</b> Ltd now owns 375,163 shares of the biopharmaceutical company's stock worth $540,000 after purchasing an additional 40,452 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up